The clinical and immunological features of patients with combined anti-glomerular basement membrane disease and membranous nephropathy

Kidney International

Volumn 85, Issue 4, 2014, Pages 945-952

  Jia, Xiao Yu ^a,b,c,d   Hu, Shui Yi ^a,b,c,d   Chen, Jun Liang ^a,b,c,d   Qu, Zhen ^a,b,c,d   Liu, Gang ^a,b,c,d   Cui, Zhao ^a,b,c,d   Zhao, Ming Hui ^a,b,c,d,e  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b PEKING UNIVERSITY   (China)

^c BEIJING HOSPITAL   (China)

^d BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^e Tsinghua University   (China)

Author keywords

Anti GBM antibodies; Antigen; Epitope; IgG subclasses; M type phospholipase A2 receptor; Membranous nephropathy

Indexed keywords

COLLAGEN ANTIBODY; COLLAGEN TYPE IV ALPHA3 CHAIN NONCOLLAGENOUS DOMAIN 1 ANTIBODY; COMPLEMENT; CREATININE; EPITOPE; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G3 ANTIBODY; M TYPE PHOSPHOLIPASE A2 RECEPTOR ANTIBODY; RECEPTOR ANTIBODY; UNCLASSIFIED DRUG; AUTOANTIBODY; PHOSPHOLIPASE A2 RECEPTOR;

ADULT; ANTIBODY BLOOD LEVEL; ANURIA; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; GOODPASTURE SYNDROME; HISTOLOGY; HUMAN; MALE; MEMBRANOUS GLOMERULONEPHRITIS; OLIGURIA; PATHOGENESIS; PRIORITY JOURNAL; RARE DISEASE; SURVIVAL; BLOOD; CASE CONTROL STUDY; COMPLICATION; GLOMERULONEPHRITIS; IMMUNOLOGY; KIDNEY; METABOLISM; MIDDLE AGED; PATHOLOGY; YOUNG ADULT;

ADULT; ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; AUTOANTIBODIES; CASE-CONTROL STUDIES; COMPLEMENT SYSTEM PROTEINS; FEMALE; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; KIDNEY; MALE; MIDDLE AGED; RECEPTORS, PHOSPHOLIPASE A2; YOUNG ADULT;

EID: 84897954374     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2013.364     Document Type: Article

References (37)

1. Lerner RA, Glassock RJ, Dixon FJ. The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis. J Exp Med 1967; 126: 989-1004.
2. Almkuist RD, Buckalew VM Jr, Hirszel P et al. Recurrence of antiglomerular basement membrane antibody mediated glomerulonephritis in an isograft. Clin Immunol Immunopathol 1981; 18: 54-60.
3. Saus J, Wieslander J, Langeveld JP et al. Identification of the Goodpasture antigen as the alpha 3(IV) chain of collagen IV. J Biol Chem 1988; 263: 13374-13380.
4. Netzer KO, Leinonen A, Boutaud A et al. The goodpasture autoantigen. Mapping the major conformational epitope(s) of alpha3(IV) collagen to residues 17-31 and 127-141 of the NC1 domain. J Biol Chem 1999; 274: 11267-11274.
5. Borza DB, Netzer KO, Leinonen A et al. The goodpasture autoantigen. Identification of multiple cryptic epitopes on the NC1 domain of the alpha3(IV) collagen chain. J Biol Chem 2000; 275: 6030-6037.
6. Vanacore R, Ham AJ, Voehler M et al. A sulfilimine bond identified in collagen IV. Science 2009; 325: 1230-1234.
7. Pedchenko V, Bondar O, Fogo AB et al. Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis. N Engl J Med 2010; 363: 343-354.
8. Klassen J, Elwood C, Grossberg AL et al. Evolution of membranous nephropathy into anti-glomerular-basement-membrane glomerulonephritis. N Engl J Med 1974; 290: 1340-1344.
9. Moorthy AV, Zimmerman SW, Burkholder PM et al. Association of crescentic glomerulonephritis with membranous glomerulonephropathy: A report of three cases. Clin Nephrol 1976; 6: 319-325.
10. Richman AV, Rifkin SI, McAllister CJ. Rapidly progressive glomerulonephritis. Combined antiglomerular basement membrane antibody and immune complex pathogenesis. Hum Pathol 1981; 12: 597-604.
11. Kurki P, Helve T, von BM et al. Transformation of membranous glomerulonephritis into crescentic glomerulonephritis with glomerular basement membrane antibodies. Serial determinations of anti-GBM before the transformation. Nephron 1984; 38: 134-137.
12. Thitiarchakul S, Lal SM, Luger A et al. Goodpasture's syndrome superimposed on membranous nephropathy. A case report. Int J Artif Organs 1995; 18: 763-765.
13. Pasternack A, Tornroth T, Linder E. Evidence of both anti-GBM and immune complex mediated pathogenesis in the initial phase of Goodpasture's syndrome. Clin Nephrol 1978; 9: 77-85.
14. Sharon Z, Rohde RD, Lewis EJ. Report of a case of Goodpasture's syndrome with unusual immunohistology and antibody reactivity. Clin Immunol Immunopathol 1981; 18: 402-414.
15. Jennette JC, Lamanna RW, Burnette JP et al. Concurrent antiglomerular basement membrane antibody and immune complex mediated glomerulonephritis. Am J Clin Pathol 1982; 78: 381-386.
16. Agodoa LC, Striker GE, George CR et al. The appearance of nonlinear deposits of immunoglobulins in Goodpasture's syndrome. Am J Med 1976; 61: 407-413.
17. Savige JA, Dowling J, Kincaid-Smith P. Superimposed glomerular immune complexes in anti-glomerular basement membrane disease. Am J Kidney Dis 1989; 14: 145-153.
18. Elder G, Perl S, Yong JL et al. Progression from Goodpasture's disease to membranous glomerulonephritis. Pathology 1995; 27: 233-236.
19. Kielstein JT, Helmchen U, Netzer KO et al. Conversion of Goodpasture's syndrome into membranous glomerulonephritis. Nephrol Dial Transplant 2001; 16: 2082-2085.
20. Zhao J, Cui Z, Yang R et al. Anti-glomerular basement membrane autoantibodies against different target antigens are associated with disease severity. Kidney Int 2009; 76: 1108-1115.
21. Zhao J, Yan Y, Cui Z et al. The immunoglobulin G subclass distribution of anti-GBM autoantibodies against rHalpha3(IV)NC1 is associated with disease severity. Hum Immunol 2009; 70: 425-429.
22. Oliveira DB. Membranous nephropathy: An IgG4-mediated disease. Lancet 1998; 351: 670-671.
23. Beck LH Jr, Bonegio RG, Lambeau G et al. M-Type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 2009; 361: 11-21.
24. Hoxha E, Harendza S, Zahner G et al. An immunofluorescence test for phospholipase-A(2)-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis. Nephrol Dial Transplant 2011; 26: 2526-2532.
25. Chen L, Hellmark T, Wieslander J et al. Immunodominant epitopes of alpha3(IV)NC1 induce autoimmune glomerulonephritis in rats. Kidney Int 2003; 64: 2108-2120.
26. Yang R, Hellmark T, Zhao J et al. Levels of epitope-specific autoantibodies correlate with renal damage in anti-GBM disease. Nephrol Dial Transplant 2009; 24: 1838-1844.
27. Bowman C, Ambrus K, Lockwood CM. Restriction of human IgG subclass expression in the population of auto-Antibodies to glomerular basement membrane. Clin Exp Immunol 1987; 69: 341-349.
28. Qu Z, Liu G, Li J et al. Absence of glomerular IgG4 deposition in patients with membranous nephropathy may indicate malignancy. Nephrol Dial Transplant 2012; 27: 1931-1937.
29. Qu Z, Cui Z, Liu G et al. The distribution of IgG subclass deposition on renal tissues from patients with anti-glomerular basement membrane disease. BMC Immunol 2013; 14: 19.
30. el-Etr M, Lombes M, Baulieu EE et al. A monoclonal anti-idiotypic 'internal image' antibody that recognizes the A1 adenosine receptor potentiates the alpha 1-Adrenergic activation of phospholipase C in primary cultures of mouse striatal astrocytes. Neurosci Lett 1992; 145: 15-18.
31. Debiec H, Ronco P. PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy. N Engl J Med 2011; 364: 689-690.
32. Hoxha E, Kneissler U, Stege G et al. Enhanced expression of the M-Type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy. Kidney Int 2012; 82: 797-804.
33. Zhang JJ, Malekpour M, Luo W et al. Murine membranous nephropathy: Immunization with alpha3(IV) collagen fragment induces subepithelial immune complexes and Fc gamma R-independent nephrotic syndrome. J Immunol 2012; 188: 3268-3277.
34. Abrahamson DR, Hudson BG, Stroganova L et al. Cellular origins of type IV collagen networks in developing glomeruli. J Am Soc Nephrol 2009; 20: 1471-1479.
35. Ehrenreich T, Churg J. Pathology of membranous nephropathy. In: Sommers SC (ed). Pathology Annual. Appleton-Century-Crofts: New York, NY, USA, 1968, pp 145-154.
36. Hellmark T, Segelmark M, Unger C et al. Identification of a clinically relevant immunodominant region of collagen IV in Goodpasture disease. Kidney Int 1999; 55: 936-944.
37. Xing GQ, Chen M, Liu G et al. Complement activation is involved in renal damage in human antineutrophil cytoplasmic autoantibody associated pauci-immune vasculitis. J Clin Immunol 2009; 29: 282-291.